Summit climbs on rumour of $15bn AstraZeneca interest
Is AstraZeneca about to join the ranks of pharma companies spending big bucks on PD(L)-1xVEGF bispecific antibodies for cancer?
NICE relents on Takeda colorectal cancer drug Fruzaqla
Colorectal cancer patients could soon have access via the NHS to a targeted oral drug that can give them more precious time with their loved ones.
The NHS 10-year plan arrives – what are the highlights?
After months of preparation and a drip-feed of some of its key features, the UK government has raised the curtain on its new 10-year plan for the NHS.
Dizal set to bring lung cancer drug Zegfrovy to US
Dizal gets US approval for an oral therapy for EGFR exon 20-mutated NSCLC, offering some patients an alternative to J&J's intravenous Rybrevant.
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
The World's Definitive Degrader & Proximity-Based Drugs Even...
The 8th Annual TPD & Induced Proximity Summit is the world’s largest and longest-standing forum for proximity-based modalities
Welcome to the 7th Exosome-Based Therapeutic Development Sum...
Accelerate Therapeutic Efficacy & Delivery Potential of Exosomes & EVs
Welcome to the 10th CDD for Biologics Summit
Accelerate Therapeutic Efficacy & Delivery Potential of Exosomes & EVs
The Inaugural Multi-Omics Based Drug Discovery & Development
The Industry-Led Forum Dedicated to Expanding the Applications of Multi-Omics Across Therapeutic Development
2nd Translational Digital Pathology & AI Summit
Don’t miss the return of this event, uniting 60+ leading biopharma pioneers driving the adoption and utilization of digital pathology